IsoTis signs agreements with orthopaedic companies

IsoTis, the Dutch biomedical company, has signed three commercial agreements with major orthopaedic companies that will contribute to revenues in 2002 through development fees and product sales. The agreements are with Smith & Nephew and Sulzer Medica to produce cement restrictors from IsoTis' proprietary biodegradable co-polymer system PolyActive and with BionX to supply PolyActive resin for the production of synthetic finger joints. No financial terms were disclosed.
Share
STIJGERS & DALERS BEL20